Malignant peripheral nerve sheath tumor
Showing 1 - 25 of >10,000
Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1, Recurrent Malignant Peripheral Nerve Sheath Tumor
Recruiting
- Metastatic Malignant Peripheral Nerve Sheath Tumor
- +2 more
- Computed Tomography
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jul 6, 2022
Development to Predict Malignant Conversion in Neurofibromatosis
Recruiting
- Neurofibromatosis 1
- +2 more
- Whole Body Magnetic Resonance Imaging
-
Baltimore, MarylandJohns Hopkins University
Dec 22, 2022
Malignant Peripheral Nerve Sheath Tumor Development in
Active, not recruiting
- Neurofibromatosis 1
- Peripheral Nerve Neoplasms, Malignant
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jul 6, 2022
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023
Peripheral Nerve Sheath Tumor Trial in Gainesville (Tazemetostat)
Recruiting
- Peripheral Nerve Sheath Tumor
-
Gainesville, FloridaUniversity of Florida
Jan 4, 2023
Malignant Peripheral Nerve Sheath Tumors (MPNST) Trial in United States (ASTX727)
Recruiting
- Malignant Peripheral Nerve Sheath Tumors (MPNST)
-
Basking Ridge, New Jersey
- +6 more
Aug 25, 2022
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- (no location specified)
Oct 17, 2022
Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene
Not yet recruiting
- Synovial Sarcoma
- +3 more
- Afamitresgene autoleucel
-
Palo Alto, California
- +3 more
Dec 6, 2022
Malignant Peripheral Nerve Sheath Tumour (MPNST) Trial in Oslo (Pembrolizumab)
Terminated
- Malignant Peripheral Nerve Sheath Tumour (MPNST)
-
Oslo, NorwayOslo university Hospital
Jun 21, 2021
Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)
Recruiting
- Soft Tissue Sarcoma
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 7, 2022
Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small
Recruiting
- Desmoplastic Small Round Cell Tumor
- +11 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jun 26, 2022
Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)
Available
- Pancreatic Cancer
- +6 more
-
Santa Monica, CaliforniaSarcoma Oncology Research Center, LLC
Jan 20, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Pharmacodynamic Study
- Telaglenastat Hydrochloride
-
Birmingham, Alabama
- +30 more
Sep 1, 2022
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022
Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle
Completed
- Adult Alveolar Soft Part Sarcoma
- +18 more
- Gemcitabine
- +5 more
-
Portland, Oregon
- +1 more
Sep 23, 2021
Pleuropulmonary Blastoma, Recurrent Malignant Peripheral Nerve Sheath Tumor, Recurrent Neuroblastoma Trial in United States
Completed
- Pleuropulmonary Blastoma
- +5 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +68 more
Jan 4, 2022
Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,
Recruiting
- Leiomyosarcoma
- +29 more
- Definitive Surgical Resection
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022
Neurofibromatosis, MPNST Trial run by the National Cancer Institute (NCI) (MRI, FDG-PET/CT scans, [18F]-FLT-PET/CT scans)
Completed
- Neurofibromatosis
- MPNST
- MRI, FDG-PET/CT scans
- [18F]-FLT-PET/CT scans
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Nerve Origin of Neck Peripheral Nerve Sheath Tumors
Recruiting
- Peripheral Nerve Sheath Tumors
- Schwannoma of Neck
- Excision
-
Taipei, TaiwanNational Cheng-Kung University Hospital
Jan 12, 2023
Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)
Active, not recruiting
- Malignant Peripheral Nerve Sheath Tumors
- Neurofibromatosis 1
-
Washington, District of Columbia
- +4 more
Apr 1, 2022
Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors Trial in Shanghai (AL2846 capsules)
Recruiting
- Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors
- AL2846 capsules
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital, School of Medicine, Shanghai J
Sep 24, 2021